How to use maturating in a sentence? Find typical usage patterns (collocations)/phrases/context for "maturating" and check conjugation/comparative form for "maturating". Mastering all the usages of "maturating" from sentence examples published by news publications.
"A "pause" may be needed so other landlords can defer interest payments if tenants can't pay rent, especially with a wave of mortgages maturating," wrote Hill in a research note.
|
|
They have reduced brain activity in the orbital prefrontal cortex, amygdala, hippocampus, temporal cortex, and brain stem. They also showed less developed white matter connections between different areas in their cerebral cortices, particularly the uncinate fasciculus. Conversely, enriching the experience of preterm infants with massage quickens the maturating of their electroencephalographic activity and their visual acuity. Moreover, as with enrichment in experimental animals, this associates with an increase in IGF-1.
|
|
Then fabelliform budding of mostly eight sporoblasts into the vesicle is initiated. Initially the wall of the encysted spore (sporont) has two layers. During the maturating of the sporont two generations of tubules are present in the episporontal space, being reduced at maturity. Mature spores of the genus Hamiltosporidium are polymorph, though pyriform and elongated rod-like spores dominate in H. tvaerminnensis while H. magnivora has lightly pyriform spores only. Pyriform spores measure 4·9–5·6 x 2·2–2·3 μm while elongated spores measure 6·8–12·0 x 1·6–2·1 μm in H. tvaerminnensis.
|
|
Within the field of child development, Jones believed there was some evidence that supported the idea that adolescent children who have started maturing (reaching puberty) at an earlier age were perceived and treated differently by their peers and other adults. In Child Development, the flagship journal of the society of Research and Child Development, published an articles were published by Paul Mussen and Mary Cover Jones (1957, 1958) and that investigated the relationship between physical maturation status and self-concepts in late- and early-maturating adolescent boys and girls, respectively. Paul Mussen and Mary Cover Jones (1957) conducted a study that investigated the relationship between maturational status and certain aspects of personality during late adolescence. Mussen and Jones believed that there is evidence that supports the notion that within our culture, adults treat boys who have started puberty at an earlier age differently from boys who have started puberty at a later age because of their physical status. The current study used multiple personality inventories that aimed to uncover aspects of late – and early- maturing boys’ personality to see if there was significant differences among the boys.
|
|
While studies are inconclusive, autologous stem cell bone marrow transplantation appears to prolong survival in early treatment failure patients who are healthy enough to withstand this therapy. Unfit patients may benefit from initial treatment with obinutuzumab plus bendamustine followed by maintenance treatment with obinutuzumab (if they have not been treated previously with obinutuzumab). Other mostly experimental treatments currently under study in patients with multiple treatment failures include: 1) Phosphoinositide 3-kinase inhibitors such as copanlisib, duvelisib, and idelalisib which block the phosphoinositide 3-kinase signaling pathway that promotes the survival, proliferation, and other potentially malignant behaviors of cells; 2) infusion of tisagenlecleucel chimeric antigen receptor T cells (i.e. CAR T cells) (i.e. T cells that have been isolated from patients, engineered to express a receptor for the CD19 protein on, and thereby kill, T cells, and then infused back into the donor patient); 3) Bruon's tyrosine kinase inhibitor, ibrutinib, to block the B-cell maturating actions of this kianase; 4) BCL inhibitor venetoclax to block Bcl2's action in promoting B-cell survival and proliferation; 5) histone deacetylase inhibitors abexinostat and tazemetostat to modify the expression of various genes; and 6) Checkpoint inhibitors nivolumab, pidilizumab, and pembrolizumab to promote the immune system's ability to suppress cancer cell growth.
|
|
No results under this filter, show 5 sentences.